GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

InBody Co 041830.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

40,550

-3.57%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩233.95bn

FY2016FY2025

Net income

₩30.63bn

FY2016FY2025

Free cash flow

₩28.36bn

FY2016FY2025

Shareholders' equity

₩317.85bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩233.95bn₩204.46bn₩170.35bn₩160.00bn₩137.84bn₩107.12bn₩117.06bn₩99.64bn₩93.25bn₩79.85bn
Gross profit₩181.01bn₩158.23bn₩132.45bn₩121.07bn₩101.32bn₩77.45bn₩86.26bn₩72.93bn₩69.46bn₩57.84bn
Research and development₩11.18bn₩11.17bn₩9.31bn₩8.78bn₩8.06bn₩5.80bn₩5.24bn₩5.21bn₩7.25bn₩5.38bn
Operating income₩36.75bn₩36.74bn₩38.35bn₩40.70bn₩35.85bn₩19.10bn₩27.43bn₩23.68bn₩24.90bn₩21.85bn
Net income₩30.63bn₩33.14bn₩36.72bn₩33.82bn₩34.03bn₩17.52bn₩20.43bn₩19.67bn₩19.32bn₩16.99bn
Diluted earnings per share2,512.482,544.192,819.012,595.832,612.571,344.761,535.761,460.301,432.651,247.88

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩361.06bn₩305.82bn₩274.46bn₩242.67bn₩203.76bn₩166.15bn₩154.90bn₩131.69bn₩112.02bn₩97.06bn
Cash and short-term investments—₩103.63bn₩98.92bn₩86.55bn₩71.43bn₩57.49bn₩41.70bn₩25.47bn₩50.38bn₩42.73bn
Total liabilities₩41.27bn₩31.91bn₩24.62bn₩27.41bn₩20.03bn₩16.09bn₩15.21bn₩7.30bn₩5.55bn₩4.76bn
Debt—₩8.42bn₩6.08bn₩6.40bn₩3.87bn₩4.79bn₩2.96bn———
Shareholders' equity₩317.85bn₩272.97bn₩248.77bn₩215.26bn₩183.73bn₩150.06bn₩139.69bn₩124.39bn₩106.48bn₩92.30bn
Shares outstanding12m13m13m13m13m13m13m13m13m14m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩35.78bn₩28.58bn₩38.69bn₩30.42bn₩30.35bn₩28.50bn₩24.21bn₩17.70bn₩18.58bn₩18.24bn
Capital spending−₩7.42bn−₩7.55bn−₩7.64bn−₩6.02bn−₩11.45bn−₩1.69bn−₩3.08bn−₩40.86bn−₩5.31bn−₩8.41bn
Free cash flow₩28.36bn₩21.03bn₩31.04bn₩24.40bn₩18.90bn₩26.81bn₩21.13bn−₩23.16bn₩13.26bn₩9.83bn
Dividends paid−₩5.04bn−₩4.56bn−₩3.91bn−₩2.61bn−₩1.82bn−₩1.86bn−₩1.62bn−₩1.62bn−₩1.36bn−₩1.09bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩73.25bn₩68.44bn₩62.40bn₩59.80bn₩56.17bn₩55.58bn₩55.07bn₩50.72bn
Gross profit₩58.91bn₩51.47bn₩48.97bn₩44.65bn₩45.12bn₩42.26bn₩42.00bn₩40.40bn
Operating income₩17.74bn₩13.02bn₩9.52bn₩9.81bn₩10.42bn₩6.15bn₩7.50bn₩9.82bn
Net income₩14.16bn₩16.33bn₩6.41bn₩9.64bn₩7.58bn₩7.00bn₩8.61bn₩7.43bn
Diluted earnings per share1,061.331,224.25480.75790.64621.48555.35664.53570.55
Cash from operations₩7.61bn₩9.79bn₩13.71bn₩9.04bn₩5.63bn₩7.40bn₩6.06bn₩8.06bn
Capital spending−₩1.30bn−₩845.0m−₩1.26bn−₩3.64bn−₩1.74bn−₩776.0m−₩2.47bn−₩1.72bn
Free cash flow₩6.32bn₩8.94bn₩12.45bn₩5.39bn₩3.89bn₩6.63bn₩3.59bn₩6.34bn
Total assets₩388.43bn₩381.13bn₩361.06bn₩318.34bn₩301.37bn₩309.62bn₩305.82bn₩303.59bn
Cash and short-term investments—————₩104.36bn₩103.63bn₩108.34bn
Debt—————₩5.31bn₩5.10bn₩4.67bn
Shareholders' equity₩344.05bn₩328.65bn₩317.85bn₩280.03bn₩268.26bn₩272.60bn₩272.97bn₩269.24bn

Financial ratios

Data as of 1 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin77.4%77.4%77.8%75.7%73.5%72.3%———
Operating margin15.7%18.0%22.5%25.4%26.0%17.8%———
Net margin13.1%16.2%21.6%21.1%24.7%16.4%———
Return on equity9.6%12.1%14.8%15.7%18.5%11.7%———
Return on assets8.5%10.8%13.4%13.9%16.7%10.5%———
Free cash flow yield———————7.1%2.9%
Revenue growth14.4%20.0%6.5%16.1%28.7%-8.5%———
Earnings growth-7.6%-9.7%8.6%-0.6%94.3%-14.2%———
Current ratio6.48x6.64x8.54x7.06x6.77x7.59x———
Debt to equity—0.00x0.00x0.00x0.00x0.00x0.02x——
Equity ratio88.0%89.3%90.6%88.7%90.2%90.3%———
Interest coverage72.88x95.64x116.38x333.62x346.39x153.42x———
R&D as a share of sales4.8%5.5%5.5%5.5%5.8%5.4%———
Buybacks as a share of market value———————0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.5%16.9%13.0%
Operating income-3.3%14.0%6.3%
Net income-3.2%11.8%5.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin77.4%77.1%76.1%75.2%
Operating margin16.8%19.8%20.5%22.1%
Net margin14.5%17.5%18.3%19.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings13.09.19.07.88.912.915.414.928.021.6
Price to sales1.71.51.91.62.22.12.72.95.84.6

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year600.00400.00350.00300.00200.00140.00140.00120.00
  • 2-for-1 split · 23 Apr 2010
  • 11-for-10 split · 28 Dec 2005
  • 11-for-10 split · 29 Dec 2004

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.